Assessment of Left Ventricular Hypertrophy and Dysfunction in Patients of Chronic Kidney Disease
Keywords:
Left Ventricular Hypertrophy, CKDAbstract
Background: India experiencing an alarming increasing the burden of non-communicable diseases, like the prevalence of obesity and diabetes mellitus. Prevalence of CKD is also rising parallel but about this disease studied done infrequently, so the data on incidence of CKD is sparse. Cardiovascular disease can causing 50% fatality in these patients irrespective of biological age. According to international registries death in dialysis population that are occurring due to cardiac disease occurring up to 40%. Cardiovascular related morbidity and mortality that are associated with LVH is highly analytical for future progression that occurring in CKD patients.Subjects and Methods: This study was done in the Department of Medicine of TMMC & RC, TMU, MORADABAD, U.P. it was a Cross-sectional Observational Study.100 cases will be taken from OPD and IPD setting in TMMC & RC, TMU, Moradabad, U.P.Diagnosed cases of CKD patients aged >18 years of both sexes
admitted in IPD or visiting to OPD in Teerthanker Mahaveer medical College & Hospital, Moradabad. Those who were give valid consent.Cases below 18years of age, pregnant women. All cases of acute renal failure. All known primary case of IHD, CHF, RHD, Cardiomyopathies and any other cardiac disorders.Results:Majority (54.0%) of sample were in the age group of 54 and above years, most (64.0%) of them were males.It revealed that, the mean body weight of the sample was 55.0±8.42 Kg, the mean Systolic Blood Pressure (mmHg) of the sample was 144.56±19.88 mmHg. Mean Diastolic Blood Pressure (mmHg) of the sample was 91.02±9.23 mmHg.ECG revealed that, around 65% of the sample had LVH.2-D ECHO-LVH/LV Function reveled that, around 36% AND 33% of the sample have Mild concentric LVH and Moderate LV systolic dysfunction and LVH respectively.Majority (71.0%) of the sample have reduced ejection fraction.Conclusion:Left ventricular hypertrophy and dysfunction is a veryimportant preventive feature of CKD associated cardiomyopathy.There is increased chance of left ventricular hypertrophy in CKD patients.With respect to category of chronic kidney disease, the LVH prevalence is progressively increases with increasing severity of CKD (chronic kidney disease).Blood pressure control is very important step to forestall the development of CKD and other related damage of end organs.
Downloads
References
1. Barsoum RS. Chronic Kidney Disease in the Developing World. New England Journal of Medicine. 2006 Mar 9;354(10):997–9. 2. Levin A. Anemia and left ventricular hypertrophy in chronic kidney disease populations: A review of the current state of knowledge. Kidney International. 2002 May 1;61:S35–8.
3. Hung M-J, Yang N-I, Wu I-W, Cheng C-W, Liu P-C, Chen S-J, et al. Three-dimensional echocardiographic assessment of left ventricular remodeling in predialysis chronic kidney disease patients. J Nephrol. 2012 Feb;25(1):96–106.
4. Otsuka T, Suzuki M, Yoshikawa H, Sugi K. Left ventricular diastolic dysfunction in the early stage of chronic kidney disease. J Cardiol. 2009 Oct;54(2):199–204.
5. Gluba-Brzózka A, Michalska-Kasiczak M, Franczyk-Skóra B, Nocuń M, Banach M, Rysz J. Markers of increased cardiovascular risk in patients with chronic kidney disease. Lipids Health Dis. 2014 Aug 21;13:135.
6. Hida S, Chikamori T, Tanaka H, Igarashi Y, Hatano T, Usui Y, et al. Diagnostic value of left ventricular function after adenosine triphosphate loading and at rest in the detection of multi-vessel coronary artery disease using myocardial perfusion imaging. J NuclCardiol. 2009 Feb;16(1):20–7.
7. Agarwal S, Dangri P, Kalra O, Rajpal S. Echocardiographic Assessment of Cardiac Dysfunction in Patients of Chronic Renal Failure. 2003;4(4):8.
8. Dangri P, Agarwal S, Kalra O, Rajpal S. Echocardiographic assessment of left ventricular hypertrophy in patients of chronic renal failure. 2003;6.
9. Dahan M, Siohan P, Viron B, Michel C, Paillole C, Gourgon R, et al. Relationship between left ventricular hypertrophy, myocardial contractility, and load conditions in hemodialysis patients: An echocardiographic study. American Journal of Kidney Diseases. 1997 Dec 1;30(6):780–5.
10. Datta S, Abraham G, Mathew M, Somasundaram H, Muralidharan T, Moorthy A, et al. Correlation of Anemia, Secondary Hyperparathyroidism with Left Ventricular Hypertrophy in Chronic Kidney Disease Patients. 2006;54:5.
11. Mailloux LU, Levey AS. Hypertension in patients with chronic renal disease. American Journal of Kidney Diseases. 1998 Nov 1;32(5):S120–41.
12. Meyer KB, Levey AS. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular disease. J Am SocNephrol. 1998 Dec;9(12 Suppl):S31-42.
13. Parfrey PS, Harnett JD, Griffiths SM, Taylor R, Hand J, King A, et al. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron. 1990;55(2):114–20.
14. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage
renal disease therapy. Kidney Int. 1995 Jan;47(1):186–92. 15. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987 Apr 15;59(9):956–60. 16. Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G. Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis. 2005 Aug;46(2):320–7.
17. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990 May 31;322(22):1561–6.
18. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, et al. Alterations of Left Ventricular Hypertrophy in and Survival of Patients Receiving Hemodialysis: Follow-up of an Interventional Study. JASN. 2001 Dec 1;12(12):2759–67.
19. Levey AS, Eckardt K-U, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International. 2005 Jun;67(6):2089–100.
20. Kartheek ASV, Reddy VCS. Assessment of cardiac dysfunction in patients with end stage renal disease in a tertiary care hospital. J Evid Based Med Healthc. 2019 Dec 6;6(24):1668–72.
21. Chillo P, Mujuni E. Prevalence and predictors of left ventricular dysfunction among patients with chronic kidney disease attending Muhimbili National Hospital in Tanzania — a cross sectional study [Internet]. Research Reports in Clinical Cardiology. 2018 [cited 2019 Oct 21]. Available from: https://www.dovepress.com/prevalence-and-predictors-of-left
ventricular-dysfunction-among-patien-peer-reviewed-article-RRCC 22. Vankayala A, Behera KL, Raju DSSK, Sayana SB. A study on the left ventricular hypertrophy among the patients of chronic kidney disease stage third to five. International Journal of Research in Medical Sciences. 2019 Apr 26;7(5):1511–4.
23. Laddha M, Sachdeva V, Diggikar PM, Satpathy PK, Kakrani AL. Echocardiographic assessment of cardiac dysfunction in patients of end stage renal disease on haemodialysis. J Assoc Physicians India. 2014 Jan;62(1):28–32.
24. Reddy KV, C A J. Prevalence of anemia and left ventricular hypertrophy and their correlation in chronic kidney disease patients. Medpulse-International Medical Journal [Internet]. 2018 May [cited 2019 Sep 20];6(2). Available from: https://www.medpulse.in/Medicine/html_6_2_11.php
25. Rudenko TE, Kamyshova ES, Vasilyeva MP, Bobkova IN, Solomakhina NI, Shvetsov MY. Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease. TerArkh. 2018 Sep 20;90(9):60–7.
26. Amoako YA, Laryea DO, Bedu-Addo G, Nkum BC, Plange-Rhule J. Left ventricular hypertrophy among chronic kidney disease patients in Ghana. Pan Afr Med J. 2017;28:79.
27. Smith David H., Thorp Micah L., Gurwitz Jerry H., McManus David D., Goldberg Robert J., Allen Larry A., et al. Chronic Kidney Disease and Outcomes in Heart Failure With Preserved Versus Reduced Ejection Fraction. Circulation: Cardiovascular Quality and Outcomes. 2013 May 1;6(3):333–42.
